A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt ...

The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell ...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer ...

Philip Tinnefeld from LMU is coordinating a new doctoral training network at the interface of physics, chemistry, biology, and engineering.

Ingrida Domarkienė, a geneticist at Vilnius University in Lithuania, discusses the exciting developments made possible by ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

Scientists at the Icahn School of Medicine at Mount Sinai have made an exciting discovery about how human cells make RNA, a ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines through its powerful computational drug discovery engine, today ...